Development of Small HN Linked Radionuclide Iodine-125 for Nanocarrier Image Tracing in Mouse Model
Ronglin Ma,Chunya Ji,Mengdan Shen,Shujuan Xu,Guojia Fan,Chengcheng Wu,Qiang Yu,Linliang Yin
DOI: https://doi.org/10.2147/ijn.s446564
IF: 7.033
2024-02-23
International Journal of Nanomedicine
Abstract:Ronglin Ma, 1, 2, &ast Chunya Ji, 1, &ast Mengdan Shen, 2 Shujuan Xu, 2 Guojia Fan, 3 Chengcheng Wu, 1 Qiang Yu, 2 Linliang Yin 1 1 Center for Medical Ultrasound, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, Jiangsu, 215002, People's Republic of China; 2 Department of Gastroenterology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, Jiangsu, 215002, People's Republic of China; 3 Center for Cytotoxicity Testing, Sanitation & Environment Technology Institute, Soochow University, Suzhou, Jiangsu, 215006, People's Republic of China &astThese authors contributed equally to this work Correspondence: Qiang Yu, Department of Gastroenterology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Jiangsu, People's Republic of China, Tel +86 512 62362045, Email Linliang Yin, Center for Medical Ultrasound, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Jiangsu, People's Republic of China, Tel +86 13382183478, Email Background: Radionuclides have important roles in clinical tumor radiotherapy as they are used to kill tumor cells or as imaging agents for drug tracing. The application of radionuclides has been developing as an increasing number of nanomaterials are used to deliver radionuclides to tumor areas to kill tumor cells. However, promoting the efficient combination of radionuclides and nanocarriers (NCs), enhancing radionuclide loading efficiency, and avoiding environmental pollution caused by radionuclide overuse are important challenges that hinder their further development. Methods: In the present study, a new small molecule compound (3-[[(2S)-2-hydroxy-3-(4-hydroxyphenyl)-1-carbonyl] amino]-alanine, abbreviation: HN, molecular formula: C 12 H 16 N 2 O 5 ) was synthesized as a linker between radionuclide iodine-125 ( 125 I) and NCs to enable a more efficient binding between NCs and radionuclides. Results: In vitro evidence indicated that the linker was able to bind 125 I with higher efficiency (labeling efficiency > 80%) than that of tyrosine, as well as various NCs, such as cellulose nanofibers, metal oxide NCs, and graphene oxide. Single-photon emission computed tomography/computed tomography imaging demonstrated the biological distribution of 125 I-labeled NCs in different organs/tissues after administration in mice. Conclusion: These results showed an improvement in radionuclide labeling efficiency for nanocarriers and provided an approach for nanocarrier image tracing. Keywords: nanocarriers, radionuclide labeling, radionuclide 125 i, SPECT/CT imaging Iodine-125 ( 125 I) is a low-power radionuclide that is widely used in biomedicine, due to its simple decay process, safe tissue penetration distance, less damage to surrounding healthy tissues, and long action time. 1,2 Its uses include cholangiocarcinoma treatment, 3 prostate cancer treatment, 4 non-small cell cancer treatment, 5 thyroid tumor tissue examination, 6 bone densitometry, 7 and isotope imaging in the clinic. 8–10 The main mechanism of action for the use of 125 I is to place it at the tumor site and kill tumor cells directly using gamma rays (0.03548 MeV) released from its decay process, thereby partially or completely eliminating the lesions and avoiding the recurrence or distant metastasis. 11 In addition, 125 I can also serve as an imaging probe for nanocarriers (NCs), 12,13 tyrosine, and proteins 14,15 in theragnostics and drug tracing. 125 I labeling on the surface of NCs or proteins is well suited for the study of its physiological roles and metabolism due to its short half-life of 60.14 days. 16–18 Thus far, near-infrared fluorescence imaging remains one of the most common imaging methodologies for in vivo visualization of NCs and protein carriers. However, it has several limitations, such as poor spatial resolution and tissue penetration. 19–21 By contrast, radionuclide imaging has high sensitivity, strong anti-interference ability, and no tissue-penetrating limitations, which can accurately reflect the distribution of radionuclide-labeled NCs or protein carriers in real time in two- or three-dimensional space in vivo.< -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology